Close Menu

NEW YORK (GenomeWeb) — German multiomics tools firm Centogene announced today that it has partnered with Evotec to discover and develop drugs for certain rare genetic diseases.

Under the terms of the strategic alliance, the companies will combine Evotec's induced pluripotent stem cell-based drug screening platform with Centogene's patient access and biomarker expertise to develop a high-throughput platform for evaluating novel small molecule treatments for rare hereditary metabolic diseases.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Oregon state Senate unanimously passed a bill that would make it easier for people convicted of crimes to initiate DNA testing of evidence, according to the Associated Press.

People reports that researchers have uncovered genetic variants that lead people to always feel full.

Florida state senators are to weigh a bill prohibiting life insurance companies from using genetic information in coverage decisions, according to Florida Politics.

In Genome Research this week: metagenomic sequencing assay that detects pathogens in cerebrospinal fluid, single-tube long fragment read approach, and more.

May
08
Sponsored by
Sysmex Inostics

This webinar will present recent evidence that demonstrates how incorporating circulating tumor DNA (ctDNA) assessments into real-world patient management can influence patient care decisions, alter radiographic interpretations, and impact clinical outcomes.